{"id":"NCT01822548","sponsor":"Azienda Ospedaliero-Universitaria di Parma","briefTitle":"Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes","officialTitle":"Randomized, Open Label, Two Parallel Arms, Intervention Trial Comparing the Effect of DPP-IV Inhibitor Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number in Patients With Type 2 Diabetes in Metformin Failure","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10","primaryCompletion":"2014-12","completion":"2015-01","firstPosted":"2013-04-02","resultsPosted":"2017-08-02","lastUpdate":"2017-08-02"},"enrollment":64,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Vildagliptin","otherNames":["LAF237A"]},{"type":"DRUG","name":"Glibenclamide","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]}],"arms":[{"label":"Vildagliptin & metformin","type":"EXPERIMENTAL"},{"label":"Glibenclamide & metformin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the effect of Dipeptidyl peptidase (DPP) -IV inhibitor Vildagliptin vs. Glibenclamide on circulating endothelial progenitor cells (EPCs) number in type 2 diabetes patients in metformin failure. Subjects will be followed for 12 months after randomization.","primaryOutcome":{"measure":"Absolute Change in the Endothelial Progenitor Cell (EPC) Number","timeFrame":"V0, V2 (month 4), V4 (12 month)","effectByArm":[{"arm":"Vildagliptin & Metformin","deltaMin":37,"sd":null},{"arm":"Glibenclamide & Metformin","deltaMin":36,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"},{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"35 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":1},"locations":{"siteCount":2,"countries":["Italy"]},"refs":{"pmids":["28231835"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":["hypoglycemia"]}}